Voss Capital, LLC Cullinan Oncology, Inc. Transaction History
Voss Capital, LLC
- $1.15 Billion
- Q4 2024
A detailed history of Voss Capital, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Voss Capital, LLC holds 122,361 shares of CGEM stock, worth $1.17 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
122,361Holding current value
$1.17 Million% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding CGEM
# of Institutions
153Shares Held
68MCall Options Held
612KPut Options Held
118K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$73.3 Million19.97% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$55.1 Million3.06% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$34 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$32.7 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.28MShares$31.5 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $437M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...